Table 3.
Clinical parameters | P value | HR | 95% CI |
---|---|---|---|
Age | 0.093 | 2.107 | 0.883–5.028 |
Gender | 0.074 | 0.377 | 0.129–1.099 |
TNM stage | 0.612 | 1.232 | 0.550–2.758 |
Lymph node metastasis | 0.743 | 0.849 | 0.320–2.258 |
ZFX expression | 0.045 | 4.997 | 1.033–24.180 |
Clinical parameters | P value | HR | 95% CI |
---|---|---|---|
Age | 0.093 | 2.107 | 0.883–5.028 |
Gender | 0.074 | 0.377 | 0.129–1.099 |
TNM stage | 0.612 | 1.232 | 0.550–2.758 |
Lymph node metastasis | 0.743 | 0.849 | 0.320–2.258 |
ZFX expression | 0.045 | 4.997 | 1.033–24.180 |